Browse by Audience
Skip to content
Papers of the Week
The short-term effects of CGRP monoclonal antibodies on bone turnover: A prospective cohort study.
Authors
Ray JC, Sztal-Mazer S, Baker J, Matharu MS, Hutton EJAbstract
Calcitonin gene-related peptide monoclonal antibodies (CGRP mAb) are an effective treatment of migraine however may have possible off-target effects. Pre-clinical studies implicate CGRP in several aspects of bone turnover and homeostasis. The clinical effect of CGRP mAb on bone turnover is not known, however.